Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,853 JPY | +1.31% | -0.04% | 0.00% |
05-06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
05-06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.15B | |
+18.02% | 339B | |
+15.38% | 73.83B | |
-7.08% | 68.53B | |
+3.61% | 30.21B | |
+24.34% | 24.26B | |
+8.95% | 14.14B | |
+16.62% | 10.13B | |
+21.30% | 9.31B | |
-4.50% | 6.73B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Telo Genomics' MRD Clinical Trial Expands into Multi-Center Trial; Shares up 9.5%